T3	Subject 0 29	A patient with generalized MG
T5	Treatment 59 61	MM
T7	Drug 59 61	MM
T10	Effect 76 88	CNS lymphoma
T11	Duration 95 102	3 years
T12	Treat-Disorder 15 29	generalized MG
T13	Treatment 59 61	MM
T6	Potential_therapeutic_event 46 53	managed
T9	Adverse_event 66 75	developed
E1	Potential_therapeutic_event:T6 arg:T5
E2	Adverse_event:T9 arg:T3 arg2:T13 arg3:T10
R1	has Arg1:T5 Arg2:T12	
R2	has Arg1:T13 Arg2:T11